alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### United States Institute of Peace

*Date/Time:*                     Thursday, January 20, 2011 (9:30 a.m.-5:30 p.m.); Friday, January 21, 2011 (9 a.m.-12:30 p.m.).                

*Location:*                     1200 17th Street, NW., Suite 200, Washington, DC 20036-3011.                

*Status:*                     Open Session—Portions may be closed pursuant to Subsection (c) of Section 552(b) of Title 5, United States Code, as provided in  subsection 1706(h)(3) of the United States Institute of Peace Act, Public Law 98-525.                

*Agenda:*                     January 20-21, 2011 Board Meeting; Approval of Minutes of the  One Hundred Thirty-Eighth Meeting (September 15, 2010) of the  Board of Directors; Chairman's Report; President's Report; Introduction of the Senior Fellows Slate; Strategic Plan Update; Building Move Issues; Board Executive Session; Other General  Issues.                

*Contact:*                     Tessie F. Higgs, Executive Office.                     *Telephone:*                     (202) 429-3836.                

Dated: December 29, 2010.

Michael Graham,

Vice President for Management and CFO, United States Institute of Peace.

[FR Doc. 2010-33246 Filed 1-5-11; 8:45 am]

BILLING CODE 6820-AR-M
Editorial Note on Part 180
Editorial Note: Nomenclature changes to part 180 appear at 79 FR 75879, Dec. 19, 2014.

§ 180.10 How is this part organized? This part is organized in two segments. ( a ) Sections 180.5 through 180.45 contain general policy direction for Federal agencies' use of the standards in subparts A through I of this part.
( b ) Subparts A through I of this part contain uniform governmentwide standards that Federal agencies are to use to specify— ( 1 ) The types of transactions that are covered by the nonprocurement debarment and suspension system;
( 2 ) The effects of an exclusion under that nonprocurement system, including reciprocal effects with the governmentwide debarment and suspension system for procurement;
( 3 ) The criteria and minimum due process to be used in nonprocurement debarment and suspension actions; and
( 4 ) Related policies and procedures to ensure the effectiveness of those actions.
§ 1150.7 Yearly class allocation. For each fiscal year, FDA will allocate the total assessment among the classes of tobacco products. ( a ) *Calculation.* FDA will calculate the percentage shares for each class as follows: ( 1 ) Except for cigars, FDA will multiply the units of product removed and not tax exempt for the most recent full calendar year by the 2003 maximum Federal excise tax rate for that class (class dollar figure).
( 2 ) For cigars, FDA will: ( i ) Multiply the units of small cigars removed and not tax exempt for the most recent full calendar year by the 2003 maximum Federal excise tax rate for small cigars (small cigar subclass dollar figure).
( ii ) Multiply the units of large cigars removed and not tax exempt for the most recent full calendar year by the 2003 maximum Federal excise tax rate for large cigars (large cigar subclass dollar figure).
( iii ) Add the small cigar subclass dollar figure and the large cigar subclass dollar figure (cigar class dollar figure).
( 3 ) FDA will total the class dollar figures for all tobacco classes for the most recent full calendar year (total dollar figure).
( 4 ) FDA will divide the class dollar figure by the total dollar figure to determine the percentage share for each class.
( 5 ) FDA will calculate the allocation for each class of tobacco products by multiplying the percentage share for each class by the total assessment.
( b ) *Reallocation.* For any class of tobacco products that is not deemed by FDA to be subject to regulation under chapter IX of the Federal Food, Drug, and Cosmetic Act, the amount of user fees that would otherwise be assessed to such class of tobacco products will be reallocated to the classes of tobacco products that are subject to chapter IX of the Federal Food, Drug, and Cosmetic Act in the same manner and based on the same relative percentages otherwise determined under paragraph (a) of this section.
[79 FR 39310, July 10, 2014, as amended at 81 FR 28716, May 10, 2016]
§ 1.1360 Under what circumstances will FDA modify the requirements in this subpart that apply to a food or type of entity or exempt a food or type of entity from the requirements of this subpart? ( a ) *General.* Except as specified in paragraph (b) of this section, FDA will modify the requirements of this subpart applicable to a food or type of entity, or exempt a food or type of entity from the requirements of this subpart, when we determine that application of the requirements that would otherwise apply to the food or type of entity is not necessary to protect the public health.
( b ) *Registered facilities.* If a person to whom modified requirements or an exemption applies under paragraph (a) of this section (including a person who manufactures, processes, packs, or holds a food to which modified requirements or an exemption applies under paragraph (a) of this section) is required to register with FDA under section 415 of the Federal Food, Drug, and Cosmetic Act (and in accordance with the requirements of subpart H of this part) with respect to the manufacturing, processing, packing, or holding of the applicable food, such person must maintain records identifying the immediate previous source of such food and the immediate subsequent recipient of such food in accordance with §§ 1.337 and 1.345. Such records must be maintained for 2 years.
Case 2:06-cv-00748-MEF-WC Document 13 Filed 10/04/2006 Page 1 of 1
#### § 1312.43 Waiver or modification of rules.

The Administrator of the presiding officer (with respect to matters pending before him) may modify or waive any rule in this part by notice in advance of the hearing, if he determines that no party in the hearing will be unduly prejudiced and the ends of justice will thereby be served. Such notice of modification or waiver shall be made a part of the record of the hearing.

[36 FR 23625, Dec. 11, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973]
### 0.8 0,7 (/) 

### 0,6 Ol 

### t: "'0 

### 0.5 t: ns 

### t: 

### 0.4 0 

# - E 0.3 

# - Q> 

# - ns 

### 0.2 

## e::: 0,1 0 

# . , , 

### i 0.70 0.69 r I ! I , 

# .- , ! , 0.50 

# .- 0.46 i


# - 0.43 

## ! 0,39 

### ,....--


## - , j "- 0.25! 

### ---, i



## - -'
"- 

## -



# . . . . . . 70'-74' 

### 00'-04'

75'-79' 80'-84' 

### 85'-89' 90'-94' 95'-99' Figure 

### 2: Landing overrun accident rate trend.~ 

# I



# .~

~ 

# \ 1...... 1\ 1..

-, 

# • . . 

# . ~...,I"'11...,N..., •..

# ...,a • • • • 

# 1"'1 N ••• 

## a 

# _rD



# ~l In 0 

# ••• 

# a. III 

# a. o 

# ••• a. o .a ••• ::IIIII 

# 1S 

# .,

# \. •

# '·'T····r

' .• 

## '. • \, 

### -\.-

-~ \,

# .

-' ..- ~. ", ~., ['. 

# - ~~' 

# 1 • 

# t ,~'1 !~~ ;;r, 

## .<::<,..)' ;:, r, 

# ~y' .. I

•0\ 'D 

# . r



# <5~" / .:::- /. 

# 1 ,I i



# ~"~;/ . " 

# <::~,,~ .'~" .x ! 

### / 

# -, ..•............ 

### "$7' / 

# o'',"~ ;:, " ..''''''' . ,.' }

. 

### ,"" ''0',/ I



### - •..

, ;

..- N k • 

## , ./ 

# . ,/ " 

# f ~'> / 

## / -e 

## /

..

~ 

# /<// L.J 

### '='
•• $i 

### // 

## / ~ I 1- / // 

# t ./ /



### - 7 ./ 

### -_.•..•-50 strength beds performances ( in knots -RW exit speed)

Aircraft Model G-IV GL-OlIU Falcon 900 t.eaqet 35 ERJ-135 Cessna 750 Hawker 125 Estimated ErvlAS Stoppnq Capabilty@speclfied operating weights 57.000 Ibs 37.0001bs 35.5001bs 14.000Ibs 41.5001bs 29000lbs 20.5001bs 250 ft bed plus 25 ftsetback (total 275 

### It RSA) high 60's 70 high 60's mid 50's mid 60's mid 60s 70 

# 250

# ft bed 

# +25

# ftsetback 

# G-IV @ 57,000 Ibs CL-600 @ 37,000 Ibs Falcon 900 @ 35,500 Ibs Lear35 @ 14,000 Ibs low 40's exit speed from bed (in knots) ERJ-135 at41 ,500 Ibs Cessna 750 at29,000 Ibs 10 knots 

# exit speed from bed (in knots) 

# Hawker 125 @ 20,500 Ibs
§ 1311.116 Additional requirements for biometrics. ( a ) If one of the factors used to authenticate to the electronic prescription application is a biometric as described in § 1311.115, it must comply with the following requirements.
( b ) The biometric subsystem must operate at a false match rate of 0.001 or lower.
( c ) The biometric subsystem must use matching software that has demonstrated performance at the operating point corresponding with the false match rate described in paragraph (b) of this section, or a lower false match rate. Testing to demonstrate performance must be conducted by the National Institute of Standards and Technology or another DEA-approved government or nongovernment laboratory. Such testing must comply with the requirements of paragraph (h) of this section.
( d ) The biometric subsystem must conform to Personal Identity Verification authentication biometric acquisition specifications, pursuant to NIST SP 800-76-1 as incorporated by reference in § 1311.08, if they exist for the biometric modality of choice.
( e ) The biometric subsystem must either be co-located with a computer or PDA that the practitioner uses to issue electronic prescriptions for controlled substances, where the computer or PDA is located in a known, controlled location, or be built directly into the practitioner's computer or PDA that he uses to issue electronic prescriptions for controlled substances.
( f ) The biometric subsystem must store device ID data at enrollment (*i.e.*, biometric registration) with the biometric data and verify the device ID at the time of authentication to the electronic prescription application.
( g ) The biometric subsystem must protect the biometric data (raw data or templates), match results, and/or non-match results when authentication is not local. If sent over an open network, biometric data (raw data or templates), match results, and/or non-match results must be: ( 1 ) Cryptographically source authenticated;
( 2 ) Combined with a random challenge, a nonce, or a time stamp to prevent replay;
( 3 ) Cryptographically protected for integrity and confidentiality; and
( 4 ) Sent only to authorized systems.
( h ) Testing of the biometric subsystem must have the following characteristics: ( 1 ) The test is conducted by a laboratory that does not have an interest in the outcome (positive or negative) of performance of a submission or biometric.
( 2 ) Test data are sequestered.
( 3 ) Algorithms are provided to the testing laboratory (as opposed to scores or other information).
( 4 ) The operating point(s) corresponding with the false match rate described in paragraph (b) of this section, or a lower false match rate, is tested so that there is at least 95% confidence that the false match and non-match rates are equal to or less than the observed value.
( 5 ) Results of the testing are made publicly available.
223 So.2d 406

#### Lawrence Paul TURNER and Paul Abraham v. W. D. EWING, Callender Auto Rental and Fidelity General Insurance Company.

No. 49843.

June 13, 1969.

In re: W. D. Ewing applying for certiorari, or writ of review, to the Court of Appeal, Fourth Circuit, Parish of Orleans. 220 So.2d 518.

It is ordered that the writ of review issue; that the Court of Appeal send up the record in duplicate of the case; and that counsel for plaintiff and defendant be notified.
§ 111.25 What are the requirements under this subpart D for written procedures? You must establish and follow written procedures for fulfilling the requirements of this subpart D, including written procedures for: ( a ) Calibrating instruments and controls that you use in manufacturing or testing a component or dietary supplement;
( b ) Calibrating, inspecting, and checking automated, mechanical, and electronic equipment; and
( c ) Maintaining, cleaning, and sanitizing, as necessary, all equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements.
Exhibit 21

List Of Subsidiaries



|                                           |  |                             
|------------------------------------------ |  | ----------------------------
|Subsidiary                                 |  | Jurisdiction of Organization
|MEMC Electronic Materials France Sarl      |  | France                      
|MEMC Electronic Materials, GmbH            |  | Germany                     
|MEMC Electronic Materials Sales, Sdn. Bhd. |  | Malaysia                    
|MEMC Electronic Materials, Sdn. Bhd.       |  | Malaysia                    
|MEMC Electronic Materials, S.p.A.          |  | Italy                       
|MEMC Electronic Materials (UK) Ltd.        |  | United Kingdom              
|MEMC Holding B.V.                          |  | The Netherlands             
|MEMC Holdings Corporation                  |  | Delaware                    
|MEMC International, Inc.                   |  | Delaware                    
|MEMC Japan Ltd.                            |  | Japan                       
|MEMC Korea Company                         |  | South Korea                 
|MEMC Kulim Electronic Materials, Sdn. Bhd. |  | Malaysia                    
|MEMC Pasadena, Inc.                        |  | Delaware                    
|MEMC Singapore Pte. Ltd.                   |  | Singapore                   
|Taisil Electronic Materials Corporation    |  | Taiwan
79–008

106TH CONGRESS REPORT " ! HOUSE OF REPRESENTATIVES 2d Session 106–752

PROVIDING FOR CONSIDERATION OF A MOTION TO GO TO

CONFERENCE ON H.R. 4810, THE MARRIAGE TAX PENALTY ELIMINATION RECONCILIATION ACT OF 2000

JULY 17, 2000.—Referred to the House Calendar and ordered to be printed

Ms. PRYCE of Ohio, from the Committee on Rules,

submitted the following

REPORT

[To accompany H. Res. 553]

The Committee on Rules, having had under consideration House

Resolution 553, by a nonrecord vote, report the same to the House

with the recommendation that the resolution be adopted.

SUMMARY OF PROVISIONS OF THE RESOLUTION

The resolution provides for the consideration of a motion to go to

conference on H.R. 4810, the Marriage Tax Penalty Elimination

Reconciliation Act of 2000. The resolution provides one hour of debate divided equally between the chairman and ranking minority

member of the Committee on Ways and Means. The resolution also

provides that House Resolution 550 is laid on the table.
§ 1.241 What are the consequences of failing to register, update, renew, or cancel your registration? ( a ) Section 301 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 331) prohibits the doing of certain acts or causing such acts to be done. Under section 302 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 332), the United States can bring a civil action in Federal court to enjoin a person who commits a prohibited act. Under section 303 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 333), the United States can bring a criminal action in Federal court to prosecute a person who is responsible for the commission of a prohibited act. Under section 306 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 335a), FDA can seek debarment of any person who has been convicted of a felony relating to importation of food into the United States. Failure of an owner, operator, or agent in charge of a domestic or foreign facility to register its facility, renew the registration of its facility, update required elements of its facility's registration, or cancel its registration in accordance with the requirements of this subpart is a prohibited act under section 301(dd) of the Federal Food, Drug, and Cosmetic Act.
( b ) FDA will consider a registration for a food facility to be expired if the registration is not renewed, as required by § 1.230(b). Thus, if you previously submitted a registration to FDA, but do not submit a registration renewal to FDA during the period beginning on October 1 and ending on December 31 of each even-numbered year, FDA will consider the registration for the facility to be expired. FDA will consider a food facility with an expired registration to have failed to register in accordance with section 415 of the Federal Food, Drug, and Cosmetic Act.
( c ) FDA will cancel a registration if FDA independently verifies that the facility is no longer in business or has changed owners, and the owner, operator, or agent in charge of the facility fails to cancel the registration, or if FDA determines that the registration is for a facility that does not exist, is not required to register, or where the information about the facility's address was not updated in a timely manner in accordance with § 1.234(a) or the registration was submitted by a person not authorized to submit the registration under § 1.225. Also, FDA will cancel a registration if the facility's registration has expired because the facility has failed to renew its registration in accordance with § 1.230(b). If FDA cancels a facility's registration, FDA will send a confirmation of the cancellation using contact information submitted by the facility in the registration database.
( d ) If an article of food is imported or offered for import into the United States and a foreign facility that manufactured/processed, packed, or held that article of food has not registered in accordance with this subpart, the disposition of the article of food shall be governed by the procedures set out in subpart I of this part.
[81 FR 45953, July 14, 2016]
#### § 1250.80 Applicability.

The sanitation facilities and the sanitary conditions on vessels engaged in interstate traffic shall comply with the requirements prescribed in this subpart, provided that no major structural change will be required on existing vessels.
[Federal Register Volume 76, Number 1 (Monday, January 3, 2011)]
[Notices]
[Page 85]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-33095]


-----------------------------------------------------------------------

DEPARTMENT OF AGRICULTURE

Forest Service


Coconino Resource Advisory Committee

AGENCY: Forest Service, USDA.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Coconino Resource Advisory Committee will meet in 
Flagstaff, Arizona, to finalize the Project Submission Form, Project 
Evaluation Checklist, and discuss any additional last minute items to 
prepare to hear proposals in the future. No proposals will be heard at 
this meeting.

DATES: The meeting will be held January 27, 2011, beginning at 1 p.m. 
to approximately 4 p.m.

ADDRESSES: The meeting will be held in the Ponderosa Room of the 
Coconino County Health Department, 2625 N. King St., Flagstaff, Arizona 
86004. Send written comments to Brady Smith, RAC Coordinator, Coconino 
Resource Advisory Committee, c/o Forest Service, USDA, 1824 S. Thompson 
St., Flagstaff, Arizona 86001 or electronically to 
<a href="/cdn-cgi/l/email-protection#9cfeeefdf8e5eff1f5e8f4dcfaefb2faf9f8b2e9ef"><span class="__cf_email__" data-cfemail="82e0f0e3e6fbf1efebf6eac2e4f1ace4e7e6acf7f1">[email protected]</span></a>.

FOR FURTHER INFORMATION CONTACT: Brady Smith, Coconino National Forest, 
(928) 527-3490.

SUPPLEMENTARY INFORMATION: Agenda items for this meeting include (1) 
Public Comment Period; (2) Project Submission Form discussion and 
finalization; (3) Project Evaluation Checklist discussion and 
finalization. The meeting is open to the public.

    Dated: December 27, 2010.
Paul Flanagan,
Acting Forest Supervisor, Coconino National Forest.
[FR Doc. 2010-33095 Filed 12-30-10; 8:45 am]
BILLING CODE 3410-11-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
[if !vml]>[endif]>

[if !vml]>[endif]>

You have reached the FederalDepository Library Program Electronic Collection (FDLP/EC) Archive. Thisarchive assures ongoing access to publications in the FDLP/EC. Access topublications in the archive is available through GPO's suite of cataloging andlocator services, including the Catalog of U.S. Government Publications(CGP).  Archived copies of publications are retrieved in the event thatpublications are no longer available from the original publishing agency site. 
**Title:****A counterdrug research anddevelopment blueprint update**
 
1995 | 1996| 1999 | 2000| 2001 | 2002| 2003
 
SuDoc Number:PREX 26.1/2:/UPDATE
Item Number:0857-R-03 (online)
CGP systemNumber:000562304
 
October 16, 2018
Exhibit 32

                            Certification Pursuant to
                             18 U.S.C. Section 1350,
      as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


     Pursuant to 18 U.S.C.  ss. 1350, as adopted  pursuant to Section 906 of the
Sarbanes-Oxley  Act of 2002,  the  undersigned  officers of Medialink  Worldwide
Incorporated (the "Company"),  hereby certify to such officers' knowledge,  that
the Company's  Quarterly Report on Form 10-Q for the quarter ended September 30,
2003 (the  "Report")  fully complies with the  requirements  of Section 13(a) or
15(d),  as  applicable,  of the  Securities  Exchange  Act of 1934  and that the
information  contained in the Report fairly presents,  in all material respects,
the financial condition and results of operations of the Company.


Dated: November 14, 2003


                                               /s/ Laurence Moskowitz
                                               -------------------------------
                                               Name:  Laurence Moskowitz
                                               Title: Chief Executive Officer


                                               /s/ J. Graeme McWhirter
                                               -------------------------------
                                               Name:  J. Graeme McWhirter
                                               Title: Chief Financial Officer



The foregoing  certification is being furnished solely pursuant to 18 U.S.C. ss.
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.